FAKTOR OPTIONSSCHEIN - STRYKER CORP. Share Price

Certificat

DE000PN3SYK0

Delayed Deutsche Boerse AG 04:20:34 03/06/2024 pm IST
56.94 EUR +3.19% Intraday chart for FAKTOR OPTIONSSCHEIN - STRYKER CORP.
1 month-2.68%
3 months-14.40%
Date Price Change
03/24/03 56.94 +3.19%
31/24/31 55.18 -1.92%
30/24/30 56.26 -0.99%
29/24/29 56.82 +3.14%
28/24/28 55.09 +2.74%

Delayed Quote Deutsche Boerse AG

Last update June 03, 2024 at 04:20 pm IST

More quotes

Static data

Product typeProduits Exotiques
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PN3SYK
ISINDE000PN3SYK0
Date issued 21/01/2022
Strike 341.1 $
Maturity Unlimited
Parity 1 : 1
Emission price 50
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 69.69
Lowest since issue 18.6
Spread 3.44
Spread %5.70%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
341.1 USD
Average target price
373.1 USD
Spread / Average Target
+9.38%
Consensus